Retrospective Study
Copyright ©The Author(s) 2016. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Clin Pediatr. Feb 8, 2016; 5(1): 95-101
Published online Feb 8, 2016. doi: 10.5409/wjcp.v5.i1.95
Analysis of the therapeutic evolution in the management of airway infantile hemangioma
Grecia V Vivas-Colmenares, Israel Fernandez-Pineda, Juan Carlos Lopez-Gutierrez, Miguel Angel Fernandez-Hurtado, Maria Antonia Garcia-Casillas, Jose Antonio Matute de Cardenas
Grecia V Vivas-Colmenares, Israel Fernandez-Pineda, Miguel Angel Fernandez-Hurtado, Jose Antonio Matute de Cardenas, Department of Pediatric Surgery, Virgen del Rocio Children’s Hospital, 41013 Sevilla, Spain
Juan Carlos Lopez-Gutierrez, Department of Pediatric Surgery, La Paz’s Children’s Hospital, 28046 Madrid, Spain
Maria Antonia Garcia-Casillas, Department of Pediatric Surgery, Gregorio Marañon Children’s Hospital, 28009 Madrid, Spain
Author contributions: Vivas-Colmenares GV, Fernandez-Pineda I, Lopez-Gutierrez JC, Fernandez-Hurtado MA, Garcia-Casillas MA and Matute de Cardenas JA designed the editorial article and wrote the manuscript; all authors had read and approved the final version to be published.
Institutional review board statement: The study was reviewed and approved by the Virgen del Rocio Children’s Hospital, La Paz’s Children’s Hospital and Gregorio Marañon Children’s Hospital Institutional.
Informed consent statement: All study participants, or their legal guardian provided informed verbal consent prior to study enrollment.
Conflict-of-interest statement: The authors declare that there is no conflict of interest.
Data sharing statement: Technical appendix, statistical code, and dataset available from the corresponding author at josea.matute.sspa@juntadeandalucia.es. Participants gave verbal consent.
Open-Access: This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Correspondence to: Jose Antonio Matute de Cardenas, MD, Department of Pediatric Surgery, Virgen del Rocio Children’s Hospital, Av. Manuel Siurot s/n, 41013 Sevilla, Spain. josea.matute.sspa@juntadeandalucia.es
Telephone: +34-95-5012924 Fax: +34-95-5012936
Received: July 23, 2015
Peer-review started: July 27, 2015
First decision: August 26, 2015
Revised: September 25, 2015
Accepted: October 23, 2015
Article in press: October 27, 2015
Published online: February 8, 2016
Processing time: 188 Days and 2.9 Hours
Core Tip

Core tip: Through this study we want to highlight the importance of early use of propranolol in the treatment of airway infantile hemangioma. We also want to show our experience with other treatment options including corticosteroids, interferon and surgical and endoscopic treatments used before the propranolol era.